批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
| 审批日期 | 提交号 | 审批结论 | 提交分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2006/09/15 |
ORIG-1(原始申请) |
Approval |
Type 1 - New Molecular Entity |
PRIORITY
|
|
|
>>>补充申请<<<
| 审批日期 | 提交号 | 审批结论 | 补充类别或审批类型 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2024/10/25 |
SUPPL-33(补充) |
Approval |
Labeling-Patient Package Insert,Labeling-Package Insert |
STANDARD
|
|
|
| 2022/01/20 |
SUPPL-27(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2022/01/13 |
SUPPL-28(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2022/01/03 |
SUPPL-30(补充) |
Approval |
Labeling-Container/Carton Labels |
STANDARD
|
|
|
| 2020/09/16 |
SUPPL-26(补充) |
Approval |
Labeling-Package Insert,Labeling-Patient Package Insert |
STANDARD
|
|
|
| 2019/03/11 |
SUPPL-24(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2019/02/21 |
SUPPL-25(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2018/01/04 |
SUPPL-22(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2016/09/09 |
SUPPL-21(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs. |
| 2016/04/11 |
SUPPL-19(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 2015/11/13 |
SUPPL-20(补充) |
Approval |
Labeling-Package Insert,Labeling-Patient Package Insert,Labeling-Container/Carton Labels |
STANDARD
|
|
|
| 2015/11/13 |
SUPPL-18(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2015/08/13 |
SUPPL-17(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 2015/07/14 |
SUPPL-16(补充) |
Approval |
Labeling-Container/Carton Labels |
STANDARD
|
|
|
| 2015/06/15 |
SUPPL-15(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 2014/06/16 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 2014/01/07 |
SUPPL-13(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 2012/06/21 |
SUPPL-12(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2012/06/21 |
SUPPL-11(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2010/09/08 |
SUPPL-8(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2009/02/19 |
SUPPL-7(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2008/05/20 |
SUPPL-6(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2008/05/20 |
SUPPL-2(补充) |
Approval |
Labeling |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
>>>活性成分:POSACONAZOLE; 剂型/给药途径:SUSPENSION;ORAL; 规格:40MG/ML; 治疗等效代码:AB<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 022003 |
001 |
NDA |
NOXAFIL |
POSACONAZOLE |
SUSPENSION;ORAL |
40MG/ML |
Prescription |
Yes |
Yes |
AB |
2006/09/15
|
SCHERING |
| 208773 |
001 |
ANDA |
POSACONAZOLE |
POSACONAZOLE |
SUSPENSION;ORAL |
40MG/ML |
Prescription |
No |
No |
AB |
2020/05/15
|
HIKMA |